<DOC>
	<DOCNO>NCT02162355</DOCNO>
	<brief_summary>The purpose multiple ascend dose study characterize safety , tolerability , amount GLPG0634 present blood urine ( pharmacokinetics ) daily oral administration GLPG0634 3 different dose level 10 day Japanese healthy subject . Furthermore , study compare safety , tolerability , pharmacokinetics , effect GLPG0634 mechanism action-related parameter blood ( pharmacodynamics ) daily oral administration GLPG0634 give one dose level 10 day Japanese vs Caucasian healthy subject .</brief_summary>
	<brief_title>Multiple Ascending Dose Study GLPG0634 Japanese Caucasian Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Male female Japanese Caucasian subject 2065 year age ( include ) Subjects must body mass index 1828 kg/mÂ² ( include ) Subjects must judge good health base upon result medical history , physical examination , vital sign , 12lead electrocardiogram laboratory profile A subject know hypersensitivity ingredient study drug significant allergic reaction drug Concurrent participation participation within 3 month prior initial study drug administration drug/device biologic investigational research study A subject active drug alcohol abuse within 2 year prior initial study drug administration Subject express current desire ( ) child Female subject le 6 month postpartum , postabortion post lactation prior study drug administration pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>